The Effect of Diabetes Mellitus on Breast Cancer


  • Devy Hanandary Ghassani Universitas Lampung
  • Indri Windarti Medical Faculty, Lampung University
  • Betta Kurniawan Medical Faculty, Lampung University


Breast cancer, cancer risk, diabetes mellitus


Breast cancer is the leading cause of death in women worldwide. The prevalence of breast cancer in the world reached 2.26 million cases in 2020, and in Indonesia it reached 16.6% around 65,858 for the last 5 years. One of the breast cancer risk factors is the presence of comorbid diseases such as diabetes mellitus. The incidence of diabetes mellitus in the world reaches 537 million people and 6.7 million people die from diabetes mellitus. Breast cancer and diabetes are the main causes of morbidity and mortality worldwide. High glucose levels in diabetes are expected to contribute to the incidence of breast cancer. Therefore, this literature study was conducted to determine the effect of diabetes mellitus on breast cancer. Based on literature studies, diabetes mellitus has effect on the incidence of breast cancer in women. There is increased risk of breast cancer in women with diabetes mellitus and the presence can lead to a poor prognosis through various mechanisms. Breast cancer screening needs proactively in women with diabetes mellitus to find cancer at the earliest possible stage. Lifestyle modification and regular medication in patients with diabetes mellitus also need to be done to reduce the risk of breast cancer.


Sung H, Ferlay J, Siegel R, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. ACS Journals. 2021;71(3):209-249.

Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95(1130):7-9. doi:10.1259/BJR.20211033

WHO. Cancer Fact Sheet for Indonesia in 2020. International Agency for Research on Cancer; 2020.

Kemenkes RI. Penyakit Kanker di Indonesia Berada Pada Urutan 8 di Asia Tenggara dan Urutan 23 di Asia. Ditjen Pencegahan dan Pengendalian Penyakit. Published 2019. Accessed November 14, 2022.

United Nations Development Programme. Human Development Report. United Nations. Published 2022. Accessed November 14, 2022.

Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—An updated review. Cancers (Basel). 2021;13(17):1-30. doi:10.3390/cancers13174287

Nechuta S, Lu W, Zheng Y, et al. Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Stud. NIH. 2018;139(1):227-235. doi:10.1007/s10549-013-2521-2.Comorbidities

Ryu TY, Park J, Scherer PE. Hyperglycemia as a Risk Factor for Cancer Progression. Diabetes Metab J. 2014;38(5):330–336. doi:10.4093/dmj.2014.38.5.330

Eketunde AO. Diabetes as a Risk Factor for Breast Cancer. Cureus. 2020;12(5):8010. doi:10.7759/cureus.8010

Li W, Zhang X, Sang H, et al. Effects of hyperglycemia on the progression of tumor diseases. J Exp Clin Cancer Res. 2019;38(327):1-7.

Perkeni. Pedoman Pengelolaan Dan Pencegahan Diabetes Melitus Tipe 2 Di Indonesia. PB Perkeni; 2021.

American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care. 2022;45(1):17-38.

Kemenkes RI. Riset Kesehatan Dasar. Kemenkes RI; 2018.

IDF. IDF Diabetes Atlas 2021. 10th ed. International Diabetes Federation; 2021.

Boyle P, Boniol M, Koechlin A, et al. Diabetes and breast cancer risk : a meta-analysis. 2012;107(9):1608-1617. doi:10.1038/bjc.2012.414

Liao S, Li J, Wei W, et al. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev. 2012;12(4):1061-1065.

Liaw Y-P, Ko P-C, Jan S-R, et al. Implications of Type1/2 Diabetes Mellitus in Breast Cancer Development: A General Female Population-based Cohort Study. J Cancer. 2015;6(8):734-739. doi:10.7150/jca.12197

Zhao X-B, Ren G-S. Diabetes mellitus and prognosis in women with breast cancer A systematic review and meta-analysis. Medicine (Baltimore). 2016;95(49):5602. doi:10.1097/MD.0000000000005602

Ali M, Kahattab N, Shabil A El. Relationship between Diabetes Mellitus and Clinicopathological Stages of Breast Cancer at Diagnosis. Benha Med J. 2020;37(2):65-80. doi:10.21608/BMFJ.2020.103526

Zhou Y, Zhang X, Gu C, Xia J. Influence of diabetes mellitus on mortality in breast cancer patients. ANZ J Surg. 2015;85(12):972-978.

Durrani IA, Bhatti A, John P. The prognostic outcome of ‘type 2 diabetes mellitus and breast cancer’ association pivots on hypoxia-hyperglycemia axis. Cancer Cell Int. 2021;21(351):115-120. doi:10.1186/s12935-021-02040-5

Ballotari P, Vicentini M, Manicardi V, et al. Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy. BMC Cancer. 2017;17(1):703. doi:10.1186/s12885-017-3696-4.

Bollig-Fische A, Dewey TG, Ethier SP. Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells. PLoS One. 2011;6(3):17959. doi:10.1371/journal.pone.0017959.

Ferroni P, Riondino S, Buonomo O, Palmirotta R, Guadagni F, Roselli M. Type 2 diabetes and breast cancer: The interplay between impaired glucose metabolism and oxidant stress. Oxid Med Cell Longev. 2015;2015. doi:10.1155/2015/183928

Tameemi W Al, Dale TP, Al-Jumaily RMK, Forsyth NR. Hypoxia-Modified Cancer Cell Metabolism. Front Cell Dev Biol. 2019;7(4):229-235. doi:10.3389/fcell.2019.00004

Catrina S-B, Okamoto K, Pereira T, Brismar K, Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes. 2014;53(12):3226-3232. doi:10.2337/diabetes.53.12.3226

Triner D, Shah YM. Hypoxia-inducible factors: a central link between inflammation and cancer. J Clin Invest. 2016;126(10):3689-3698. doi:10.1172/JCI84430

Balamurugan K. HIF-1 at the crossroads of hypoxia, inflammation, and cancer. Int J Cancer. 2016;138(5):1058-1066. doi:10.1002/ijc.29519

Dong C, Yuan T, Wu Y, et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell Int. 2013;23(3):316-331. doi:10.1016/j.ccr.2013.01.022

Takatani-Nakase T, Matsui C, Maeda S, Kawahara S, Takahashi K. High glucose level promotes migration behavior of breast cancer cells through zinc and its transporters. PLoS One. 2014;9(2):e90136. doi:10.1371/journal.pone.0090136

Shao S, Gill AA, Zahm SH, et al. Diabetes and Overall Survival among Breast Cancer Patients in the U.S. Military Health System. Cancer Epidemiol Biomarkers Prev. 2018;27(1):50-57. doi:10.1158/1055-9965.EPI-17-0439